STAT

‘We have entered a new era’: Cancer researchers no longer follow a single path to discovery

At a STAT panel, experts highlighted the tantalizing ways in which scientists hope to make progress against cancer, even as steep challenges remain.
Prostate cancer cells seen under the microscope.

CAMBRIDGE, Mass. — Blocking tumor progression. Developing liquid biopsies. Engaging patients to find personalized treatments.

They are all tantalizing ways in which scientists hope to make progress against cancer, a panel of experts noted Wednesday, even as steep challenges remain and the conversation around treatment evolves.

“We have entered a new era,” said Tyler

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A 486% Drug Price Hike, AstraZeneca CEO Pay, And More
Is there any circumstance when a 486% increase for a medicine might be justified? A small company called Harrow argues the case for an injectable eye treatment.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related